Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Nasopharyngeal Neoplasms × spartalizumab × Clear all

Phase

Phase 2 2 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 4 Melanoma 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Squamous Cell Non-small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Nasopharyngeal Neoplasms 1 Locally Advanced Low Rectal Adenocarcinoma 1 HER2+ Breast Cancer 1 Epstein-Barr Virus Infections 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colorectal Neoplasms 1

Interventions

Gemcitabine 11 Cisplatin 11 Radiotherapy, Intensity-Modulated 6 tislelizumab 2 nimotuzumab 2 camrelizumab 2 Fluorouracil 2 Carboplatin 2 spartalizumab 1 sintilimab 1 sargramostim 1 pembrolizumab 1 fosaprepitant 1 etoposide phosphate 1 Tropisetron 1 Radiotherapy 1 Induction Chemotherapy 1 Ifosfamide 1 Etoposide 1 Docetaxel 1 Dexamethasone 1 Chemotherapy, Adjuvant 1 Chemoradiotherapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03700476 2023-03-28

CONTINUUM

Sun Yat-sen University

Phase 3 Unknown

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡